[144] Walmart Inc. SEC Filing
Rhea-AI Filing Summary
Walmart Inc. (WMT) Form 144 shows a proposed sale of 58,248 shares of common stock through Arvest Wealth Management on 08/28/2025. The shares were acquired on 03/07/2022 as equity grants from Walmart Inc.; the filer records 116,568 shares acquired and indicates payment was all paid in full on 01/31/2024. The filing lists two recent sales by C. Douglas McMillon of 19,416 shares each on 06/26/2025 and 07/24/2025, with gross proceeds of $1,887,011.72 and $1,855,839.74 respectively. The filer affirms no undisclosed material adverse information.
Positive
- Clear disclosure of proposed sale date, broker, number of shares, and acquisition history
- Detailed past sales are reported with dates and gross proceeds, enhancing transparency
- Attestation that the filer does not possess undisclosed material adverse information
Negative
- Insider selling activity: proposed sale of 58,248 shares and recent sales may be viewed negatively by some investors
- Form lacks context about any trading plan adoption date (Rule 10b5-1) which could clarify timing
Insights
TL;DR: Routine insider sale notice disclosing planned sale and recent dispositions; transaction sizes are immaterial relative to shares outstanding.
The Form 144 documents a planned sale of 58,248 Walmart shares executed through a broker on 08/28/2025 and notes recent sales in June and July 2025. Acquisition of the shares sold traces to equity grants on 03/07/2022. Given the issuer's large share count (7,980,418,164 outstanding) these reported transactions represent a very small percentage of total equity and are typical periodic dispositions by an insider. The filing provides required transparency but does not contain operational or financial performance details.
TL;DR: Disclosure aligns with Rule 144 requirements; signature attestation preserves compliance with trading rules and anti-fraud representations.
The notice includes the standard attestation that the filer is not aware of material nonpublic information and references Rule 10b5-1 plan language without indicating a plan date. The document identifies broker details and exact proceeds from recent sales, which supports governance transparency. There is no indication of unusual timing or concentration that would raise governance red flags in this filing alone.